Walter - Walter R Wasylaschuk

Mr. Walter - Walter R Wasylaschuk


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
WWWalter - Walter R Wasylaschuk
Walter - Walter R Wasylaschuk
PHPaul A. Harmon
Paul A. Harmon
GWGabriella Wagner
Gabriella Wagner
AHAmy B. Harman
Amy B. Harman
ATAllen C. Templeton
Allen C. Templeton
RRRobert A. Reed
Robert A. Reed

23 June 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RDRunqiao Dong
Runqiao Dong
JDJames DiNunzio
James DiNunzio
BRBrian P. Regler
Brian P. Regler
WWWalter - Walter R Wasylaschuk
Walter - Walter R Wasylaschuk
ASAdam Socia
Adam Socia
Axel ZeitlerAxel Zeitler
Axel Zeitler
The kinetics of water transport into tablets, and how it can be controlled by the formulation as well as the tablet microstructure, are of central importance in order to design and control the dissolution and drug release process, especially for immediate release tablets. This research employed terahertz pulsed imaging to measure the process of water penetrating through tablets using a flow cell. Tablets were prepared over a range of porosity between 10% to 20%. The formulations consist of two drugs (MK-8408: ruzasvir as a spray dried intermediate, and MK-3682: uprifosbuvir as a crystalline drug substance) and NaCl (0% to 20%) at varying levels of concentrations as well as other excipients. A power-law model is found to fit the liquid penetration exceptionally well (average R2>0.995). For each formulation, the rate of water penetration, extent of swelling and the USP dissolution rate were compared. A factorial analysis then revealed that the tablet porosity was the dominating factor for both liquid penetration and dissolution. NaCl more significantly influenced liquid penetration due to osmotic driving force as well as gelling suppression, but there appears to be little difference when NaCl loading in the formulation increases from 5% to 10%. The level of spray dried intermediate was observed to further limit the release of API in dissolution.

23 September 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
AHAshley Lynn Hardy
Ashley Lynn Hardy
EZEmily Zhang
Emily Zhang
HDHarrison Davis
Harrison Davis
JVJosef Vlasak
Josef Vlasak
MWMingzhang Wang
Mingzhang Wang
WWWalter - Walter R Wasylaschuk
Walter - Walter R Wasylaschuk
Background: Unintended particle formation in vaccine samples has the potential to reduce product efficacy and impact immunogenicity. As a result, regulatory agencies routinely request tests to analyze particles in the micron size range for release. Particles may come in a variety of forms and can be inherent (e.g., from proteinaceous aggregates) or intrinsic (e.g., silicone oil from tubing or contamination from the manufacturing process) and can range in size from submicron to the visible size range. In recent years, there has been an increased interest in developing methods to detect and monitor aggregated particles as well as a desire to evaluate particle size and concentration of submicron particles in addition to the subvisible ranges routinely monitored by compendial methods. Methods: Typically utilized techniques include biophysical analytical methodologies that leverage light scattering or imaging. In this study, dynamic light scattering (DLS), micro-flow imaging (MFI), and flow virometry were evaluated as methods to detect and monitor submicron- to micron-sized particles. Results: These methods enabled assessments of stability and processability for drug substance (DS) and drug product (DP) samples of a Human Cytomegalovirus (HCMV) vaccine candidate. For this attenuated live virus vaccine candidate, MFI and flow virometry proved to be the most sensitive methods to monitor aggregate formation over the complete size range of potential aggregates. These established methods were applied to a coxsackievirus A21 vaccine candidate for process and formulation screening. Conclusions: MFI was most sensitive to changes in subvisible particle concentration of samples that were stressed via constant stirring, while flow virometry captured changes in submicron particles after stress from stirring and recirculation with a shear cell. This comprehensive screening approach combining multiple analytical methods to screen the full aggregate particle size range coupled with a broad range of forced aggregation conditions provides a framework for screening and development of vaccine formulation candidates and other modalities, such as biologics.